Related Experiment Video
Updated: Jun 21, 2025

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface
Published on: May 21, 2015
Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance
Jiali Yu1, Yijian Yan1, Shasha Li1
1Department of Surgery, University of Michigan Medical School, Ann Arbor, MI, USA; Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.
B7-H4 acts as an onco-fetal immune checkpoint, crucial for both cancer progression and pregnancy. Targeting the progesterone-driven pathway offers a new strategy for treating B7-H4-positive cancers.
Area of Science:
- Immunology
- Reproductive Biology
- Oncology
Background:
- Immune tolerance mechanisms are critical in both cancer and pregnancy.
- B7-H4 (VTCN1) is identified as a key player in these shared processes.
Purpose of the Study:
- To investigate the role of B7-H4 in cancer and pregnancy immune tolerance.
- To elucidate the regulatory mechanisms of B7-H4 expression by female hormones.
- To explore therapeutic strategies targeting the B7-H4 pathway in cancer.
Main Methods:
- Cross-analysis of single-cell RNA-sequencing data from human cancers and the maternal-fetal interface.
- Utilizing allogeneic pregnancy models and MMTV/DMBA-induced breast cancer models.
- Progesterone receptor (PR) binding site analysis and investigation of the PR-P300-BRD4 axis.
- Assessing the efficacy of PR antagonists and BRD4 degraders in a murine cancer model.
Main Results:
- B7-H4 deficiency led to immune activation and fetal resorption in pregnancy models.
- B7-H4 promoted breast cancer progression and CD8+ T cell exhaustion.
- Progesterone directly stimulates B7-H4 expression in placental and cancer cells via the PR-P300-BRD4 axis.
- Therapeutic targeting of the PR-P300-BRD4 axis enhanced immunotherapy in a B7-H4+ breast cancer model.
Conclusions:
- B7-H4 serves as an onco-fetal immune checkpoint, linking progesterone to immune tolerance.
- The progesterone-PR-P300-BRD4 axis is a critical regulator of B7-H4 expression.
- Targeting this axis presents a promising therapeutic avenue for B7-H4-positive cancers, potentially improving immunotherapy outcomes.
Related Concept Videos
Teratogenicity
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Gonadal and Placental Hormones
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
Ovarian Cycle
Regulation of Hematopoietic Stem Cells

